Liver cancer surgery complication targeted in new drug trial
NCT ID NCT02799212
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study tested if somatostatin, a drug that lowers blood pressure in the liver, can prevent dangerous fluid buildup after liver cancer surgery. 179 patients with liver cancer and underlying liver disease took part. The goal was to see if the drug reduces the need for drainage or extra procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHM - Hôpital de la Timone
Marseille, France
-
APHP - Hôpital Beaujon
Clichy, France
-
CHRU Lille - Hopital Huriez
Lille, France
-
CHU Rennes - Hôpital Pontchaillou
Rennes, France
-
CHU de Bordeaux - Hôpital Haut Lévèque
Pessac, France
-
CHU de Toulouse - Hopital Rangueil
Toulouse, France
-
Hospices Civils de Lyon - Hôpital de la Croix Rousse
Lyon, 69004, France
Conditions
Explore the condition pages connected to this study.